The U.S. Food & Drug Administration (FDA) has just announced that it will be launching a new research program called the Medication Exposure in Pregnancy Risk Evaluation Program to study the effects of prescription drugs taken during pregnancy. The program is a collaborative effort between the FDA and researchers at the HMO Research Network Center for Education and Research in Therapeutics (CERT), Kaiser Permanente, and Vanderbilt University.
According to a new study, most mothers have taken at least one prescription drug during pregnancy, yet little is known about the actual risks of taking such drugs, such as the development of birth defects, because clinical research regarding drug safety during pregnancy is scant. This new program should provide the answers that doctors need for prescribing medications and allow expectant mothers to make informed decisions regarding the health of themselves and their babies.
Read more about the details of this new study at injuryboard.com.